360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Peter Loftus

Type: Person

Name: Peter Loftus

First reported May 10 2013 - Updated May 10 2013 - 1 reports

Abbott Laboratories

AbbVie Chief Scientific Officer John Leonard to Retire

AbbVie Inc. (ABBV), the pharmaceutical business spun off from Abbott Laboratories (ABT), said its head of research and development will retire from the company.In a filing with the Securities and Exchange Commission Friday, AbbVie said John M. Leonard, ... [Published Capital.gr - May 10 2013]

Entities: ABBVIE INC., John Leonard, Research & Development, Abbott Laboratories

First reported May 06 2013 - Updated May 07 2013 - 1 reports

Eli Lilly & Company

UPDATE: Lilly CEO To Have Artery Surgery, Seen Returning By Fall

--CEO Lechleiter to undergo surgical repair of enlarged aorta on May 13--Lilly CFO Rice to become acting CEO during surgery and recovery period--Lead director Marram to become acting chairperson of board(Adds details about surgery beginning in 2nd pa ... [Published Capital.gr - May 06 2013]

Entities: Eli Lilly & Company, John Lechleiter, Artery, Aorta

First reported May 06 2013 - Updated May 07 2013 - 1 reports

AbbVie's Investigational Hepatitis C Virus Regimen Gets Breakthrough-Therapy Designation

AbbVie Inc. (ABBV) said its investigational regimen for the hepatitis C virus obtained a breakthrough-therapy designation from the U.S. Food and Drug Administration.The biopharmaceutical company said the designation is intended to expedite the development ... [Published Capital.gr - May 06 2013]

Entities: Hepatitis C Virus, investigational, AbbVie

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Actavis

UPDATE: Actavis Swings to 1st-Quarter Loss on ...

--Actavis posts first-quarter loss on acquisition, restructuring charges--Company raises 2013 earnings forecast, citing strong performance--CEO declines comment on reports of M&A talks with Valeant, says company routinely explores deals(Adds details about ... [Published ADVFN UK - May 02 2013]

Entities: Actavis, Valeant Pharmaceuticals International, Acquisition, Peter Loftus

First reported May 01 2013 - Updated May 01 2013 - 2 reports

Merck & Co Inc

UPDATE: Merck 1st-Quarter Profit Down on Loss of ...

--Merck first-quarter sales disappoint, lowers 2013 outlook--Sales of diabetes drug Januvia post rare decline amid new competition--CEO says Merck will deploy more resources toward Januvia(Adds comments from Merck CEO beginning in 6th paragraph.) By Peter ... [Published ADVFN UK - May 01 2013]

Entities: Merck & Co Inc, SITAGLIPTIN, Singulair, Drugs, Peter Loftus

First reported Apr 30 2013 - Updated Apr 30 2013 - 3 reports

Pfizer Inc

3rd UPDATE: Pfizer 1st-Quarter Profit, Sales Miss Estimates as

--Pfizer first-quarter sales and earnings fall short of analysts' views on currency, other headwinds--Company still grappling with loss of exclusivity for cholesterol drug Lipitor--Pfizer reduces 2013 financial outlook(Adds comments from Pfizer CEO beginning ... [Published Nasdaq - Apr 30 2013]

Entities: Pfizer Inc, Xeljanz, Drugs, Lipitor

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Bristol-Myers Squibb Company

UPDATE: Bristol-Myers Profit Drops 45% on Lower Heart Drug Sales

--Bristol-Myers still feeling fallout from lost patent protection on Plavix --"Unremakable quarter" for Bristol-Myers, analyst says--Investors focused on pipeline, including key cancer treatment(Adds stock quote and analyst comment, beginning in paragraph ... [Published Capital.gr - Apr 25 2013]

Entities: Bristol-Myers Squibb Company, Drugs, Plavix

First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Bristol Says Results of Hepatitis C Drug Trial are Positive

An experimental drug cocktail from Bristol-Myers Squibb Co. ( Bristol Myers Squibb Co.) The company had to shift gears after a major setback last year, when another hepatitis C drug in development was linked to serious safety concerns. Bristol scrapped ... [Published 4 Traders - Apr 23 2013]

Entities: Bristol, Hepatitis C, Drugs

First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Health-Care Companies Report Slowdown in Patient Visits

The spike late last year in doctor and hospital visits apparently lasted as long as the flu.After years of decelerating health-care usage--linked to economic problems in the U.S. and Europe--the recent uptick increased optimism that a corner was being ... [Published Capital.gr - Apr 23 2013]

Entities: Patient, Johnson & Johnson, Health Management Associates Inc, Influenza

First reported Apr 20 2013 - Updated Apr 20 2013 - 1 reports

No More Lunches and Better Sales Calls

Advanced SearchProvider StrategyThe pharmaceutical industry is cutting out the lunches for doctors. Should HME sales pros do likewise?This past week the Wall Street Journal featured an article titled, â,â written by Peter Loftus. This article brought ... [Published Home Health Products - Apr 20 2013]

Entities: Bello, Peter Loftus, Ablation, Eli Lilly & Company

First reported Apr 17 2013 - Updated Apr 17 2013 - 2 reports

JOHNSON & JOHNSON: Jury Finds J&J Not Liable in 2nd Hip-Replacement Trial

Johnson & Johnson (JNJ) won a legal victory Tuesday when an Illinois jury found the company not liable for damages in a lawsuit filed by a woman who claimed she was injured by the company's all-metal hip-implant product.It was the second trial among about ... [Published 4 Traders - Apr 17 2013]

Entities: Johnson & Johnson, DePuy Inc, Peter Loftus, Implants, Circuit Court

First reported Apr 13 2013 - Updated Apr 13 2013 - 1 reports

Even Toads Have Guardian Angels

Why did the toad cross the road? To mate, of course! Each spring, the Roxborough section of Philadelphia is filled with toads crossing to a reservoir mating spot. Hundreds of volunteers gather to rescue them from motorists. WSJ's Peter Loftus reports ... [Published Palm Beach Interactive - Apr 13 2013]

Entities: Peter Loftus, Philadelphia (Pennsylvania, United States)

More Content

sort by: Date \| Relevance
2nd UPDATE: Actavis to Buy Warner Chilcott For ... [Published Nasdaq - 2 hours ago]
Drug Firms Stalk Actavis Deal [Published 4 Traders - May 16 2013]
Pair of Studies Show Power of Immune System to ... [Published Capital.gr - May 15 2013]
AbbVie Chief Scientific Officer John Leonard to... [Published Capital.gr - May 10 2013]
Pfizer Has Second Recall of Thyroid-Disorder Dr... [Published 4 Traders - May 10 2013]
UPDATE: Lilly CEO To Have Artery Surgery, Seen ... [Published Capital.gr - May 06 2013]
AbbVie's Investigational Hepatitis C Virus Regi... [Published Capital.gr - May 06 2013]
UPDATE: Actavis Swings to 1st-Quarter Loss on ... [Published ADVFN UK - May 02 2013]
UPDATE: Merck 1st-Quarter Profit Down on Loss o... [Published ADVFN UK - May 01 2013]
UPDATE: Merck 1st-Quarter Profit Down on Loss o... [Published Nasdaq - May 01 2013]
3rd UPDATE: Pfizer 1st-Quarter Profit, Sales Mi... [Published Nasdaq - Apr 30 2013]
2nd UPDATE: Pfizer 1st-Quarter Profit Up 53% on... [Published ADVFN UK - Apr 30 2013]
2nd UPDATE: Pfizer 1st-Quarter Profit Up 53% on... [Published Nasdaq - Apr 30 2013]
2nd UPDATE: Pfizer 1st-Quarter Profit Up 53% on... [Published Capital.gr - Apr 30 2013]
UPDATE: Bristol-Myers Profit Drops 45% on Lower... [Published Capital.gr - Apr 25 2013]
Bristol-Myers 1st-Quarter Net Drops 45% on Lowe... [Published Capital.gr - Apr 25 2013]
Health-Care Companies Report Slowdown in Patien... [Published Capital.gr - Apr 23 2013]
Bristol Says Results of Hepatitis C Drug Trial ... [Published 4 Traders - Apr 23 2013]
No More Lunches and Better Sales Calls [Published Home Health Products - Apr 20 2013]
Merck CEO Pay Rises but Still Nicked by Researc... [Published 4 Traders - Apr 18 2013]
JOHNSON & JOHNSON: Jury Finds J&J Not Liable in... [Published 4 Traders - Apr 17 2013]
Jury Finds J&J Not Liable in 2nd Hip-Replacemen... [Published Capital.gr - Apr 17 2013]
JOHNSON & JOHNSON: J&J Sales Rise, Helped By Re... [Published 4 Traders - Apr 16 2013]
3rd UPDATE: J&J Sales Rise, Helped By Return of... [Published Capital.gr - Apr 16 2013]
JOHNSON & JOHNSON: J&J 1st-Quarter Profit Off 1... [Published 4 Traders - Apr 16 2013]
Even Toads Have Guardian Angels [Published Palm Beach Interactive - Apr 13 2013]
Even Toads Have Guardian Angels [Published WSJ.com Video - News - Apr 13 2013]
Some Drug Makers Cut Payments, Meals Provided t... [Published PharmaGossip - Apr 11 2013]
Some Drug Makers Cut Payments, Meals Provided t... [Published 4 Traders - Apr 10 2013]
Merck 's Frazier uses the "R" word [Published PharmaGossip - Jan 03 2013]

Blogs

sort by: Date \| Relevance
Some Drug Makers Cut Payments, Meals Provided t... [Published PharmaGossip - Apr 11 2013] via foxbusiness.com wo pharmaceutical companies that are among the biggest payers of fees to doctors reduced such spending last year by double-digit percentages, as greater transparency sheds light on the hundreds of millions of dollars the industry ...
Merck 's Frazier uses the "R" word [Published PharmaGossip - Jan 03 2013] Merck CEO Sees More Drug-Industry ConsolidationBy Peter LoftusMerck CEO Ken Frazier said today that there could be further consolidation in pharmaceutical industry because of pressures on drug pricing and ever-rising research costs.“I think there’s a ...
Pfizer's Gold Dust Makes it to the WSJ [Published In the Pipeline - Dec 12 2012] I wanted to congratulate the commenters around here - your knowledge (and your low-pH wit) have propelled the Pfizer gold dust speculation here to Peter Loftus' Corporate Intelligence blog at the Wall Street Journal . Don't expect any response from ...

Audio/Video

sort by: Date \| Relevance
Even Toads Have Guardian Angels [Published WSJ.com Video - News - Apr 13 2013]